|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 31 - 40 of 657:
Use of Influenza Medicines in Urgent Crisis, Diagnostic Test in Response to Swine Flu Outbreak in Humans Permitted by FDA
In response to requests from the U.S. Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, has issued Emergency Use Auth...
Connection of Raw Alfalfa Sprouts To Salmonella Contamination
The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) recommended that consumers not eat raw alfalfa sp...
Commencement of New Envirosealed Computer Workstation for Food Processors by CCS-Inc.
New Envirosealed TECStation 1806 workstation of CCS-Inc. will be unveiled at this year’s Food Safety Summit in Washington, D.C. This rugged workstatio...
Monthly Injectable Drug for Treating Three Types of Immune-Related Arthritis Approved by FDA
Simponi (golimumab), a monthly treatment for adults with moderate-to-severe rheumatoid arthritis, active psoriatic arthritis, and active ankylosing sp...
Insights into Avian Flu Virus from FDA Researchers
It is better explained by the findings of the U.S. Food and Drug Administration scientists and collaborators what part of the “bird flu” virus is seen...
Foundation of Oral Cancer Calls for FDA Authority Over Tobacco Marketers
The Oral Cancer Foundation called for the U.S. Senate to grant the U.S. Food and Drug Administration (FDA) authority over tobacco products in response...
Violations Resulted in Restrictions on Coast IRB by FDA
Coast IRB, LLC of Colorado Springs, Colo., has agreed to willingly stop some aspects of its clinical trial oversight operations due to serious concern...
Interim Plan to Avoid Shortage of Medically Necessary Opioid Adopted by FDA
The U.S Food and Drug Administration modified its March 30, 2009, action warning manufacturers to stop the production and distribution of certain unap...
Report of FDA on the Voluntary Withdrawal of Raptiva From the U.S. Market
The manufacturer of the psoriasis drug Raptiva (efalizumab), Genentech, announced that it has begun a voluntary, phased withdrawal of the product from...
New and Quick Test for Avian Influenza A Virus in Humans Cleared by FDA
The U.S. Food and Drug Administration cleared for marketing a new, qick rapid test for the detection of influenza A/H5N1, a disease-causing subtype of... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2010 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |